PD-0729 Variable RBE for a proton therapy class solution in a randomised trial for high-risk prostate cancer. (May 2022) - Lie Aas, K.; Klitgaard, R.; Vestergaard, A.; Rønde, H.S.; Tilbæk, S.; Stolarczyk, L.; Stagaard Johansen, T.; Petersen, S.E.; Bentzen, L.; Muren, L.P.